Dr. Oz’s online health site seeks addiction expert, Dr. Cidambi’s views on Probuphine, which was recently approved by the FDA. Probuphine is intended for treatment for opioid dependence and it is used to treat individuals suffering from opiate withdrawal and opiate cravings. Dr. Cidambi, Center for Network Therapy’s medical director argues why Probuphine will flop.